Outposts of Tyranny, To be Dealt with One by One

first_img Tracking the “unidentified yellow substance” being dried out near the Yongbyon Nuclear Center [imText1]President Bush gave state of the union address on Wednesday as his administration entered its second term. Many people paid special attention on what Bush would say in regards to North Korea. Many were worried if Bush will be too harsh on North Korea, but now they are interpreting Bush’s mere mention of North Korea as Bush’s will to solve nuclear problem with North Korea. In his entire speech, the only thing Bush said about what American will do with North Korea was, “We will work closely with our coalition to deny terrorists.” However, Bush’s remarks are not enough to predict whether America will have a hard-line policy or soft-line policy toward North Korea. Bush’s state of the union address focused more on the domestic matters than international matters, for the first time in a long time. The ratio of domestic to foreign the speech consisted of was about 7:5, where domestic matters was addressed more than international matters. Bush’s remarks on the domestic matters was a declaration that his administration will maintain policies closer to free market economy principles, which were the center of the dramatic growth of the US economy after Reagan. Success Experience of Democracy, Assured to be Realized throughout the WorldIf President Bush’s remarks on international politics are to be summarized in once sentence, it could be “Report on Success of the US war in Iraq.” One third of the Bush’s remarks on international matters focused on Iraq. Although US won the war with Iraq, it has been criticized that it has not won the politics. On January 30, high number of voters in the presidential election in Iraq became clear evidence of American success in Iraq. It has come a proof that even the people in the Middle East long for democracy and that it is possible to establish a democratic government in the Middle East. Bush has taken this kind of experience as American success and has articulated that America will spread democracy throughout the world. President Bush said that the number of regimes that sponsor terror or harbor terrorists are decreasing but they cannot get out of the American sight and they will pay the price for what they have done. “They could attack our allied or attempt to blackmail the United States. In any of these cases, the price of indifference would be catastrophic. … And all nations should know: America will do what is necessary to ensure our nation’s security.” President Bush mentioned Syria and Iran among the Middle East nations, but made clear that his foreign policy is a worldwide strategy by saying, “ Together with friends and allies from Europe to Asia, and Africa to Latin America, we will demonstrate that the forces of terror cannot stop the momentum of freedom.” From the beginning, the second term Bush administration changed the term “Axis of Evil,” which stands for terrorists supporting nations, to “Outpost of Tyranny.” There is a difference between axis and outposts in how they must be dealt with. Unlike “axis,” “outposts” can become clear targets to be attacked for destruction. The term “tyranny” also made clear that America’s target for war against terrorism has changed from “those nations making nuclear weapons or weapons of mass destruction” to “nations that make its people suffer.” As sure as he can be, President Bush has declared, “We are witnessing landmark events in the history of liberty.” “Events like monuments in the history of freedom” refers to Afghanistan and Iraq that was able to elect their own president according their free will and Libya that became friends with the Western world for the first time in decades. Bush further declared, “And in coming years, we will add to that history.” It is not a question that North Korea is included in the list of the countries Bush administration would try to add as the monuments in the history of freedom. (Lee Chun Kun / vice-President of Center for Free Enterprise) By Daily NK – 2005.02.04 5:59pm AvatarDaily NKQuestions or comments about this article? Contact us at [email protected] Outposts of Tyranny, To be Dealt with One by One Analysis & Opinion RELATED ARTICLESMORE FROM AUTHOR Facebook Twittercenter_img Analysis & Opinion Analysis & Opinion Analysis & Opinion Is Nuclear Peace with North Korea Possible? SHARE Pence Cartoon: “KOR-US Karaoke”last_img read more

Learn more →

Lawmakers scrutinize drug-injury related legal ads

first_imgLawmakers scrutinize drug-injury related legal ads The Florida Legislature is exploring regulating legal advertisements seeking potential clients who may have been harmed by prescription drugs or medical devices — although there may be no Florida lawyers or law firms running such ads.The House Subcommittee on Civil Justice held a January 16 workshop on the issue. In the Senate, Sen. Tom Wright, R-Port Orange, has introduced SB 1288, which would make it a first-degree misdemeanor for failing to make certain disclaimers and disclosures in ads or trying to look like official government warning.The legislative activity follows a letter sent by the Federal Trade Commission to seven law firms and legal aggregator companies last September. The FTC said misleading ads could cause harm to consumers if they stop taking prescribed medication or using medical devices.According to Wright’s bill, the ads have flashing words like “medical alert,” “health alert,” “consumer alert,” “public service announcement;” may refer to a recall when no government agency has made a recall; and may use the seal of the Food and Drug Administration or a seal that appears to come from a government agency. They may also fail to reveal the drug or device retains FDA approval, who the sponsor of the ad is, that it is a solicitation for legal services, or state where the legal services would be provided.The FTC did not name the seven “legal practitioners and lead generators” that received its letter, but during the Civil Justice meeting, William Large, of the Florida Justice Reform Institute, said his research showed none of the seven were in Florida, and most or all were trying to attract potential clients that they then referred to other law firms.One, he said, was a Texas law firm that, despite running more than 11,000 ads, has only 20 cases throughout the country, which showed it is referring inquiries, and another is a California company with a post office box address.“The problem is not Florida Bar members,” Large said. “The problem is lead generators and aggregators who are out of state.”The subcommittee invited testimony from Florida Bar Ethics Counsel Elizabeth Tarbert, Florida State University Law Professor Elissa Gentry, and Jimmy Gustafson, a partner at Searcy, Denney, Scarola, Barnhart & Shipley.Tarbert outlined how the Bar regulates lawyer advertising and said The Florida Bar is considered to have the strictest lawyer advertising rules in the nation. In response to a question, Tarbert said the Bar cannot directly regulate out-of-state legal aggregators or lead companies, but can discipline Bar members who take cases from companies or law firms that do not follow Bar advertising and solicitation rules.Gentry said, “There seems to be good evidence that drug injury advertisements do affect risk perception.” However, she added that studies don’t yet show that those ads affect behavior.Gustafson — who said his firm might write about dangerous prescription drugs and medical devices on its blog but does not advertise on the issue — warned legislators that regulating lawyer advertising is difficult because it is protected commercial speech.“Truthful lawyer advertisements that tell the truth about dangers of drugs or devices is protected First Amendment speech,” he said. “It does a public service; it does a public good.”He also noted that drug companies have been deficient in reporting adverse reactions to the FDA, and the reports that are submitted are many times incomplete. A Harvard study, he continued, showed 1.9 million people are hospitalized each year after taking prescription drugs, 840,000 patients in hospitals have severe reactions to medications, and 128,000 people die each year after taking prescriptions.Gustafson said The Florida Bar already does a good job of regulating lawyer ads, adding, “I am personally proud of the system that the Bar has put in, I’m proud of the way they enforce it…. I think it’s fair and I think it’s rigorous and I think they do a good job with it.”He also explained his firm’s decision to advertise, saying partners determined years ago that, “If you’re not going to advertise, you’re going to end up working for somebody who does.”Civil Justice Subcommittee Chair Rep. Bob Rommel, R-Naples, indicated the House subcommittee is likely to pursue the issue.“We definitely don’t want to infringe on the First Amendment, but we may need to do something to help, even if it helps save one life,” he said. “We hear in these chambers all the time that even if it saves one life, it’s worth doing.”SB 1288 acknowledges that under the Florida Constitution, the Supreme Court regulates lawyers and that Bar rules regulate advertising. But it also finds that “the pervasive extent of these unethical practices necessitates that the Legislature exercise the state’s police power to further curtail these unethical practices….”The bill specifies anyone who violates its provisions violates the state’s deceptive and unfair trade law (Fla. Ch. 501) and commits a first-degree misdemeanor. If the advertising intended to get confidential health information to sell or otherwise benefit the advertiser, then the violation becomes a second-degree felony.The bill has been assigned to the Criminal Justice, Judiciary, and Rules committees but has not been placed on an agenda. Jan 24, 2020 By Gary Blankenship Senior Editor Top Storieslast_img read more

Learn more →

Reports probe Tamiflu benefits, call for clinical data transparency

first_imgDec 9, 2009 (CIDRAP News) – In an update of a review on the role of neuraminidase inhibitors in seasonal flu prevention and treatment, the authors reversed a previous conclusion that oseltamivir (Tamiflu) prevents complications like pneumonia in healthy patients because they were unable to reconstruct the data in one of the key studies that found a benefit.The review was published today in the British Medical Journal (BMJ), along with an investigation that the journal conducted with England’s Channel 4 News on the authors’ attempts to obtain the raw data from Roche, which supported the earlier studies and is the maker of Tamiflu.The BMJ’s investigative report and an accompanying editorial say difficulties the review authors had in verifying the data cloud government stockpiling policies and point to other problems with drug company transparency in the drug approval process and medical journal publishing practices. They also wrote that an earlier Cochrane Library review, published in 2006, should have been more rigorous.Though today’s BMJ articles focus on seasonal flu and healthy patients, they may have implications for pandemic flu, because Tamiflu is the drug of choice for managing H1N1 infections, especially in those with severe illness and those at high risk for complications.Analysis includes 20 studiesThe research team, which included experts from Australia and a doctoral student from the Massachusetts Institute of Technology, analyzed 20 published trials on neuraminidase inhibitor use in seasonal flu that focused on prevention, treatment, and adverse reactions. However, they dropped eight trials that were included in the 2006 review, because they were never published and the researchers weren’t able to verify the results. According to the BMJ investigative report, Roche wouldn’t send the authors the raw data without a signed confidentiality agreement.They concluded that neuraminidase inhibitors have a modest effect against seasonal flu symptoms in healthy adults, but a scarcity of good data undermines the previous finding that Tamiflu is useful in preventing flu complications. The investigators wrote that independent randomized trials are needed to resolve uncertainties.During negotiations with the authors over the raw data, Roche sent them a group of observational studies. An analysis of those studies in the same issue of BMJ found that oseltamivir may reduce the risk of pneumonia in healthy patients who have flu, but the benefit is small and side effects and safety should be considered. The authors of the analysis also said interpreting the observational studies was difficult, because some patients were included in more than one study.In an editorial in the same issue of BMJ, the journal’s editor-in-chief, Dr Fiona Godlee, and Mike Clarke, director of the Cochrane Centre in Oxford, England, wrote that Roche hasn’t done anything wrong by current pharmaceutical standards, but they said the current system isn’t working and “gives a false sense of security.”They wrote that drug company studies are often shrouded in secrecy and aren’t always subject to full independent review. They call for more publicly funded trials and said governments should pass laws requiring access to raw data on licensed drugs.Data access limitedFred Hayden, MD, a virologist at the University of Virginia and coordinator of influenza activities at the Wellcome Trust, an independent medical research funding charity based in London, was the corresponding author of an analysis that included raw data from some of the Roche-supported studies that Australian researchers couldn’t obtain from Roche. That report, published in a 2003 issue of Archives of Internal Medicine, has been widely use to support Tamiflu use for preventing flu-related pneumonia and hospitalizations. Hayden said that after several moves he was unable to track down the raw data and advised them to request it from Roche.Hayden told CIDRAP News that the 2003 findings are still valid and that he supports the researchers’ access to the primary data. Roche said in a response to BMJ that it would provide the raw data to researchers who have a legitimate need for it on a password-protected Web portal. “There’s no question that this is the right thing to do,” Hayden said.The new BMJ review might send a confusing message to clinicians who are in the midst of treating pandemic H1N1 patients, Hayden said. He said the review focuses on uncomplicated seasonal influenza, and he cautioned physicians not to generalize too broadly from it in their management of pandemic H1N1 cases.Studies on patients with H5N1 avian influenza infections from different countries have shown that early oseltamivir treatment can reduce mortality, and clinicians are seeing the same pattern for patients with pandemic H1N1 flu.Hayden is part of a World Health Organization (WHO) panel of antiviral experts that met in June to update WHO guidance for pandemic H1N1 management. He said the group meets again in January to review the most recent data, and he doesn’t think the BMJ review will have much of an impact on the discussions.WHO evaluating reportsCharles Penn, PhD, a scientist with the WHO’s global influenza program, told CIDRAP News that the WHO is still evaluating all of the BMJ reports to see how they might affect its antiviral guidelines. However, he said the review isn’t based on any new evidence and that its conclusions contain findings about neuraminidase inhibitor use that are already well known, such as a modest benefit in otherwise healthy patients.He pointed out that the pandemic H1N1 virus is affecting a different age range than seasonal flu, with a small number of very severe cases, including some involving viral pneumonitis. Researchers are building up a body of evidence from 6 months of clinicians’ experience in managing pandemic H1N1 patients, and the data suggest oseltamivir is having an impact on severity and hospitalizations.When queried about a response from the Centers for Disease Control and Prevention (CDC) to the BMJ review, CDC spokesman Tom Skinner referred CIDRAP News to a recent perspective article by Tim Uyeki, MD, MPH.Uyeki, a medical epidemiologist in the CDC’s Influenza Division, wrote in a Nov 18 article in the New England Journal of Medicine that evidence “supports the benefit of neuraminidase inhibitors (oseltamiviror zanamivir) in reducing complications, including deaths, among hospitalized patients with 2009 pandemic influenza A (H1N1).”Uyeki cited three observational studies of oseltamivir in seasonal flu that showed reduced mortality in hospitalized patients.”Taken together,” Uyeki concluded, “although data are limited, findings of observational studies all point in the same direction, suggesting benefit of early neuraminidase inhibitor treatment for hospitalized influenza patients as well as for patients presenting >48 hours after illness onset.”Some conclusions already acceptedVincent Racaniello, PhD, professor of microbiology at Columbia University and author of Virology Blog, told CIDRAP News that the BMJ studies are well done and the conclusions are valid, but he said scientists have known for a long time that neuraminidase inhibitors are marginally effective. “They were approved because there are no other antivirals available,” he said. “In people with lab-confirmed influenza, they work about 70% of the time in reducing symptoms by a day. That’s been known for years and these meta-analyses confirm that.”He said the new BMJ review’s conclusion that there is no benefit from postexposure prophylaxis for influenza-like illness contradicts earlier studies, but he said some of the illnesses might not have been flu and may not have been affected by neuraminidase inhibitors. “That’s one reason why the authors of this study call for more trials,” Racaniello said. The other reason they support more study is because they’re not sure that the drugs don’t prevent complications, he added.The issue the BMJ articles raise about the release of clinical trial data is “terrific,” Racaniello said. “This is immediately relevant because, for example, many people would like to see the results of H1N1 clinical trials before deciding to take the vaccine. They aren’t widely available, yet the vaccine is in use,” he added.Racaniello predicted that the new review won’t have much affect on policies regarding the use of neuraminidase inhibitors. The drugs help, even if experts aren’t sure if they help with complicated influenza, he said. “The study emphasizes the fact that we don’t have very good drugs against influenza and we need to have more. Some are in development, but it’s not enough.”Jefferson T, Jones M, Doshi P. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009 Dec 8;339 (Early online publication) [Full text]Cohen D. Complications: tracking down the data on oseltamivir. BMJ 2009 Dec 8; web extra [Abstract]Freemantle N, Calvert M. What can we learn from observational studies of oseltamivir to treat influenza in healthy adults? BMJ 2009 Dec 8;339 [Full text]Godlee F, Clarke M. Why don’t we have all the evidence on oseltamivir? BMJ 2009 Dec 8;339 (Editorial) [Full text]See also:Uyeki T. Antiviral treatment for patients hospitalized with 2009 influenza A (H1N1). N Engl J Med 2009 Nov 18 [Full text]last_img read more

Learn more →

Rioters in Guinea burn down police buildings in mining town of…

first_imgHundreds of rioters in the Guinean bauxite mining town of Boke burned down a police and a gendarmerie building on Thursday and clashed with security forces wielding batons, leaving 17 people injured, the local Red Cross said.Guinean authorities managed to avoid the bloodshed of previous days by desisting from using live bullets on the demonstrators in the Boke neighborhood of Kolabounyi, Guinean Red Cross member Oumar Kalissa told Reuters by telephone.Rioting by angry youths – who say bauxite mining has brought constant pollution and noise but no jobs or services like water and electricity – has paralyzed Boke for most of the past week.Despite decades of mining, Guinea, Africa’s top bauxite producer, remains one of the world’s least developed countries.The mines around Boke produce some 15 million tonnes of aluminum ore for the West African nation’s largest mining companies Societe Miniere de Boke (SMB) and Companie Bauxite de Guinee (CBG), but their operations have repeatedly halted in the past week and are currently still blocked by demonstrators.CBG is 49 percent owned by the Guinean state and the remainder by Alcoa, Rio Tinto Alcan [RIOXXA.UL] and Dadco. SMB is owned by Guinea, China’s Winning Shipping Ltd, Shandong Weiqiao [SDWQP.UL] and UMS International Ltd.“The Government strongly condemns these acts which are clearly outside law,” government spokesman Damantang Albert Camara said in a statement.last_img read more

Learn more →

Jumping In The City draws big Limerick crowds

first_img Tags: Limerick Greyhound Stadium, The Underwriting Exchange Limited Jumping In The City Jumping In The City draws big Limerick crowds Jumping In The City Grand Prix winner Dean Rogan THE first of the new The Underwriting Exchange Limited Jumping In The City series, which will be held in three venues during June, drew a capacity crowd to Limerick Greyhound Stadium this evening (Friday).Spectators watched show jumping in three different competitions, starting with the West Wood Ifor Williams Amateur Speed Class, which was won by Aileen McDermott from Co Westmeath riding the Irish Sport Horse Kilcor Amber.Dean Rogan from Co Sligo with Falco Van Spieveld was triumphant in the next competition, The Underwriting Exchange Limited Grand Prix, while the much-anticipated Devenish Puissance saw Liam O’Meara and Cisero the only competitor to clear the wall at its final height of two metres.The series moves on to Cork next Friday (June 12th), where Olympic Bronze medallist Cian O’Connor and Cork’s own Billy Twomey have been confirmed as entries. Twomey will ride his 17-year-old mare Tinka’s Serenade, with whom he competed at the London 2012 Olympic Games. It is believed that Twomey also intends to tackle the Puissance on the night.O’Connor will ride Quidam’s Cherie, the 10-year-old mare on whom he has jumped several Nations’ Cups for Ireland. Also joining the start list will be Tipperary’s Greg Broderick, fresh from his Nations’ Cup double clear at St Gallen. They will join former world champion Dermott Lennon and the Irish Sport Horse Loughview Lou Lou in the star-studded line-up.The final of The Underwriting Exchange Limited Jumping In The City series is due to take place at Shelbourne Park stadium in Dublin on June 26th.Full results for each competition can be found below:center_img 5 June 2015, 23:45 Home  »  Disciplines News  »  Showjumping News  »  Jumping In The City draws big Limerick crowds last_img read more

Learn more →

Andy Blackwell – A man of many sports—but a Hall-of-Famer in baseball

first_imgPittsburgh native Andy Blackwell—a man who, at first, was known as the “only Black guy on the team”—turned out to be the best guy on the team, and a Hall-of-Famer.Gone are the days when 20 percent of the Major Leagues were filled with Black baseball players. And nowadays, it’s hard to find a baseball team of any level that’s even 10 percent Black.But the baseball bug bit Blackwell as a kid, and it took him to his highest levels in the world of athletics.“I found that I had the most success as a child in baseball,” Blackwell told the New Pittsburgh Courier in an exclusive interview. “Baseball was bigger in Black communities back then.”Blackwell played in the late 1980s and early 1990s for in the Uptown Little League, winning championships in tournaments held in Brookline. “I had a lot of fun, winning, playing as a child in baseball.”Blackwell remembers having a parade through the middle of the old Martin Luther King Jr. Field in the Hill District. It was there that he played for the Cardinals. “I was 8 years old…my first little league game I hit a home run, and I felt confident from there,” Blackwell recalled. “When I became 10, 11, 12 years old, teams didn’t want to pitch to me. I was just ahead, above kids at 10 years old when they were 12.”Blackwell went on to star at quarterback for Westinghouse High School, while also starring in baseball and basketball. He graduated in 1997. Blackwell then spent time playing baseball for Garrett Community College (Md.), the Canton, Ohio Crocodiles, semi-pro team North Pittsburgh, and then for St. Johns Lefty’s Saints. With the St. Johns team, Blackwell won multiple local championships, made multiple trips to the semi-pro baseball World Series and won the National Amateur Baseball Federation (semi-pro) World Series in 2013 in Battle Creek, Michigan.But Blackwell’s on-field successes didn’t come without some direct—and indirect—backlash.“When I went to play professional baseball, it was like, ‘who are you?’ I was the only Black guy on the team, I had braids in my hair, other racist stuff I had to deal with,” Blackwell said about his time with some of the teams. “They were calling me Snoop Dogg, the coach didn’t think I could play, didn’t even put me in the game for three or four months. He had no conversation for me, but one day I got in the game and went 3-for-3, and I told him I could really play.”Blackwell said he still didn’t get into the starting lineup, and he “was getting no fun out of sitting on the bench, and I knew the guys playing weren’t better than me.”Better late than never, Blackwell eventually got his chance, and the rest is history.“I was a center fielder, batted .400, and for 10 years of the league I led in runs scored and stolen bases. No hitting the ball to center field, everything was caught,” Blackwell said about his time with St. Johns, where he never experienced direct or indirect discrimination.ANDY BLACKWELL, left, was a standout quarterback for Westinghouse in the mid-1990s.Blackwell was inducted into the semi-pro baseball Hall of Fame in Evansville, Indiana in 2014. He was among the youngest players ever selected to that Hall.“It was a feeling of joy,” Blackwell told the Courier about his Hall of Fame selection. “When you play semi-pro, you feel like you’re playing for the love, and to actually get something out of it was pure joy. I made history and I was proud of myself.”When you play semi-pro ball, said Blackwell’s coach, Tom McCarthy, “you love playing baseball. It’s not the easiest commitment, but the guys who have played for us, they still continue to be highly-dedicated to playing. They are the kids that are going to be there every night, and Andy was like that. You knew he would be there.”McCarthy said Blackwell’s biggest talents were his “speed, hitting, defense…he had everything and every tool you would expect or want out of a player.”Though Blackwell retired in 2015, McCarthy told the Courier he has been in talks with Blackwell about returning to the field if an age 28-and-up league is formed.But for now, Blackwell is focused on getting today’s Black kids hip to the games they love—baseball, basketball, or football. Blackwell currently is a football coach for the Homewood Bulldogs (ages 13-14). “I think I have the skills, and I know what to teach the kids,” he said. “Teach them the proper skills and techniques and (make sure they) stick with it.“Whatever you’re into, you do it all year long, and you’ll be the best. I want to just put the excitement back into our younger kids.” PITTSBURGH’S OWN ANDY BLACKWELL was a three-sport athlete at Westinghouse High School, then became a Hall-of-Fame baseball player in the semi-pro leagues. The photos show Blackwell as a baseball player in Homewood, then as a World Series winner in the semi-pro leagues.last_img read more

Learn more →

Jorge Sampaoli has a defensive headache and calls up four B squad players

first_img CEST 16/08/2016 at 19:22 The Sevilla manager, Argentine Jorge Sampaoli, continues to have a defensive headache given the players missing due to injury and suspension.  Argentine defender Nico Pareja, who missed the first game, is still out injured. He has had to resort to calling up four youth team players to complete his 19-man squad for the second-leg of the Spanish Super Cup this Wednesday at the Camp Nou. The injuries to French centre-back Adil Rami (muscular soreness) and left-back Sergio Escudero (knock to the ribs), are added to the suspensions of two other central defenders, the Portuguese Daniel Carriço and Frenchman Timothee Kolodziejczak. EFEcenter_img Due to this, Sampaoli has had to use players from B squad ‘Sevilla Atletico’ to replace the absentees for the clash, which the Andalusians enter trailing 2-0 from the home first-leg. Another two players from the Sevilla Atletico set-up will travel to the Catalan capital, keeper Jose Antonio Caro, who was on the bench in the first-leg given the injury to David Soria, and central defender Diego Gonzalez, who was watching from the stands after missing out on the matchday squad. The Sevilla squad for Wednesday is formed by the following players: Keepers: Sergio Rico and José Antonio Caro. Defenders: David Carmona, Diego González, Gabriel Mercado, Mariano and Alex Muñoz. Midfielders: Iborra, Kiyotake, N’Zonzi, Kranevitter, Correa, Franco Vázquez, Ganso, Vitolo and Sarabia. Strikers: Konoplyanka, Ben Yedder and Vietto. Right-back David Carmona and young centre-back Alez Muñoz (signed from Hercules this season to play in the Second division) have been called up.last_img read more

Learn more →